NIVF
NewGenIvf Group LtdCompany with tickers: NIVF, NIVFW
CIK
1981662
CUSIP
G0544E139
Shares Outstanding
2,777,920
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $4,726,433 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $3,770,587 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| Gross Profit | $955,846 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| Operating Expenses | $11,682,307 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| Research & Development | — | ||||
| Operating Income | $-10,726,461 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| Net Income | $9,879,408 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| EPS (Basic) | $214.73 | USD/shares | 2025-12-31 | 20-F | 2026-03-31 |
| EPS (Diluted) | $3.04 | USD/shares | 2025-12-31 | 20-F | 2026-03-31 |